SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
OCATA THERAPEUTICS
An SI Board Since November 2010
Posts SubjectMarks Bans Symbol
134 5 0 OCAT
Emcee:  Savant Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
84Advanced Cell Technology to Announce Fourth Quarter and Year-end Results on ThurSavant-3/6/2013
83ACT’s Clinical Partner Receives FDA Approval to Initiate Clinical Trial Using thFJB-2/11/2013
82RT...Aspirin implicated in AMD & SMD risk.. huffingtonpost.com A pain-reliSavant-1/23/2013
81Patients with Better Vision to be Enrolled in ACT's Clinical Trials for MacuSavant-1/22/2013
80Advanced Cell Technology Announces Settlement of Litigation Agreement ResolvesSavant-1/18/2013
79Advanced Cell Technology Achieves Clinical Milestone Company is Halfway througSavant-1/8/2013
78Advanced Cell Technology to Present at Biotech Showcase(TM) 2013 MARLBOROUGH, Savant-1/8/2013
77New Scientist Magazine Selects ACT's Induced Pluripotent Stem (iPS) Cell-DerSavant-12/20/2012
76Advanced Cell Technology Elects Not to Complete Reverse Split MARLBOROUGH, MasSavant-12/19/2012
75ACT Announces Completion of Higher-Dosage Cohort in European Clinical Trial for Savant-12/19/2012
74First human trials involving reprogrammed stem cells could come next year By CFJB-12/13/2012
73RT... Regeneron Pharms EYLEA injection approved for the treatment of Wet Age-RelSavant-11/27/2012
72Advanced Cell Technology Announces Interim Data from Its Three Ongoing Macular Savant-11/9/2012
71Advanced Cell Technology Announces 2012 Third Quarter Results MARLBOROUGH, MasSavant-11/9/2012
70ACT Announces Scotland's NHS Lothian as Additional Site for EU Clinical TriaSavant-8/27/2012
69ACT Comments on U.S. Appeals' Court's Dismissal Ruling in Case ChallengiSavant-8/27/2012
68ACTC Patient blog. 100K cells recipient... aisquared.com She mentions she owns ASavant-8/9/2012
67ACT Announces First Dry AMD Patient Treated with Higher Dosage of Embryonic StemSavant-8/9/2012
66Advanced Cell Technology Announces 2012 Second Quarter Results MARLBOROUGH, MaSavant-8/9/2012
65ACT Treats 10th Patient in Embryonic Stem Cell Trials for Macular Degeneration Savant-7/31/2012
64ADVANCED CELL TECHNOLOGY TO ANNOUNCE SECOND QUARTER FINANCIAL RESULTS ON WEDNESSavant-7/31/2012
63ACT Issued Broad Patent for Human RPE Cells Derived From All Types of PluripotenSavant-7/31/2012
62ACT Announces First Stargardt Patient Treated With Higher Dosage of Embryonic SSavant-7/31/2012
61Shares of Advanced Cell Technology Inc. (OTC: ACTC), a biotechnology company focSavant-7/10/2012
60May 18th.. Advanced Cell Technology to Present at World Stem Cells & RegenerSavant-6/15/2012
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News